Your browser doesn't support javascript.
loading
FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma.
Zhang, Weilong; Wu, Chaoling; Geng, Shuang; Wang, Jing; Yan, Changjian; Zhang, Xiannian; Zhang, Jia-Jia; Wu, Fan; Pang, Yuhong; Zhong, Yuping; Wang, Jianbin; Fu, Wei; Huang, Xin; Wang, Wenming; Lyu, Xiaoqing; Huang, Yanyi; Jing, Hongmei.
Afiliação
  • Zhang W; Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China.
  • Wu C; Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China.
  • Geng S; Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China.
  • Wang J; Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100084, China.
  • Yan C; Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China.
  • Zhang X; Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China.
  • Zhang JJ; Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China.
  • Wu F; Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100084, China.
  • Pang Y; Department of Hematology, Beijing Chaoyang Hospital West, Capital Medical University, Beijing 100054, China.
  • Zhong Y; Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China.
  • Wang J; Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100084, China.
  • Fu W; Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China.
  • Huang X; Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100084, China.
  • Wang W; Department of Hematology, Beijing Chaoyang Hospital West, Capital Medical University, Beijing 100054, China.
  • Lyu X; School of Life Sciences, Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100190, China.
  • Huang Y; Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China.
  • Jing H; Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China.
Aging (Albany NY) ; 15(9): 3644-3677, 2023 05 06.
Article em En | MEDLINE | ID: mdl-37155154

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmocitoma / Mieloma Múltiplo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Aging (Albany NY) Assunto da revista: GERIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmocitoma / Mieloma Múltiplo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Aging (Albany NY) Assunto da revista: GERIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos